Galanthamine 是一种乙酰胆碱酯酶抑制剂，IC50为 500 nM。

Galanthamine is an acetylcholinesterase (AChE)inhibitor(IC50 : 500 nM), can reduce brain damage induced by hypoxia-ischemia.

Galanthamine is a selective, reversible competitive acetylcholinesterase inhibitor that has been approved for the symptomatic treatment of Alzheimer's disease[1]

357-70-0

C17H21NO3

287.359

加兰他敏;Galantamine

DMSO:59 mg/mL (25.32 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years